We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Series of preclinical studies demonstrate the therapeutic potential of PAT-DX1, a first-in-class, synthetically lethal DNA-binding antibody in primary brain cancers and brain metastases. Patrys...
PAT-SM6 clinical trial data from all 4 cohorts to be presented at prestigious American Society of Hematology conference From 11 currently evaluable patients, 4 (36%) experienced stable...
Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1 - Laureate Biopharmaceutical Services to manufacture lead product PAT-LM1 Appointment follows Laureate exceeding yield...
NEW YORK, May 24 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today began trading Citigroup Funding Inc.'s PACERS Linked to eBay Inc. Priced at $10.00 per unit with an initial offer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0005 | -16.6666666667 | 0.003 | 0.003 | 0.0025 | 1327992 | 0.00299313 | DE |
4 | -0.0015 | -37.5 | 0.004 | 0.004 | 0.0025 | 3353530 | 0.00301324 | DE |
12 | -0.0005 | -16.6666666667 | 0.003 | 0.005 | 0.0025 | 2973979 | 0.00347174 | DE |
26 | -0.0045 | -64.2857142857 | 0.007 | 0.0075 | 0.0025 | 2198536 | 0.00389388 | DE |
52 | -0.0055 | -68.75 | 0.008 | 0.01 | 0.0025 | 1571375 | 0.00553213 | DE |
156 | -0.0355 | -93.4210526316 | 0.038 | 0.04 | 0.0025 | 2255785 | 0.01817396 | DE |
260 | -0.0175 | -87.5 | 0.02 | 0.063 | 0.0025 | 4394553 | 0.02915489 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions